UNSPSC 85416103: The diagnosis of abnormal findings in specimens from male genital organs : abnormal level of other drugs, medicaments and biological substances

In this classification, this covers the group of activities that yields a diagnosis of abnormal findings in specimens from male genital organs: abnormal level of other drugs, medicaments and biological substances. Abnormal findings in specimens from male genital organs: abnormal level of other drugs, medicaments and biological substances is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code R86.2.

UNSPSC 85416103, Diagnosis of abnormal findings in specimens from male genital organs: abnormal level of other drugs, medicaments and biological substances (Commodity tier), shows little relevant recent activity under this code's nominal scope. The three most recent state and local opportunities tagged to this code do not involve diagnostic testing of male genital specimens or drug-level abnormality detection. Instead, the opportunities span diagnostic imaging infrastructure (PACS systems), special education contracted services, and temporary health professional staffing across multiple ancillary clinical categories. The mismatch between the code's stated scope and the work actually being solicited suggests either systematic mis-tagging in the source data or that this code does not capture material state and local procurement volume in the relevant commodity area.

Without opportunities genuinely aligned to the code's diagnostic scope, geographic concentration and issuing-body characterization cannot be reliably drawn from these records. The three posted solicitations originate from San Mateo County (California), Birdville Independent School District (Texas), and Santa Clara County (California), but none reflects the clinical laboratory or pathology diagnostic work the code nominally describes. Readers evaluating pursuit under this code should verify whether the code is actually used by state and local health systems, laboratories, or hospital networks for contracted pathology or clinical diagnostic services before investing business development effort.